Welcome

• State of the Network - Ward Cates

HIVNET/HPTN Prevention Trials

• Opportunities and Challenges in reducing heterosexual HIV transmission:  Condoms, anti-retroviral chemoprophylaxis, HSV-2 control and male circumcision - Quarraisha Abdool Karim

• HIVNET 015: predictors of seroconversion, mediators of the intervention effect and the role of substance use - Beryl Koblin (not available for publication)

• HIVNET/HPTN024

  • Introduction - Francis Martinson

  • Phase III trial of antibiotics to reduce chorioamnionitis-associated Mother-to-child transmission of HIV - George Kafulafula

  • The efficacy of antibiotics to prevent chorioamnionitis and preterm birth - Robert Goldenberg

  • HIVNET/HPTN 024: HIV incidence among infants born HIV negative - Charles Chasela

  • The HIVNET/HPTN 024 study: Timing of maternal and infant nevirapine and the risk for mother -to-child transmission of HIV - Moses Sinkala 

• Lessons learned from community integration - Seema Sahay

• Lessons learned on recruiting IDU populations - Carl Latkin

• Hormonal contraceptives and HIV acquisition study: HIVNET 021 - Tsungai Chipato (not available for publication)

• Male Circumcision - Ron Gray

• Clinical trials in women of reproductive age and the prevalence of subclinical pregnancy - Courtney Schreiber

• Lessons learned from HIVNET 012: An outsider's perspective - John James (not available for publication)

• Anticipating the efficacy of HIV pre-exposure prophylaxis - Tom Coates (presented by Ken Mayer)

• Viral resistance with topical RT-Microbicides - Ian McGowan

• Sexual behaviors in women participating in HPTN trials - 

  • HPTN 055 Demographic and Behavioural Factors Associated with HIV - Gita Ramjee

  • Reconsidering Microbicide Eligibility Criteria - Nancy Padian

Contributions to Cross-Network Efficiencies - Jim Kublin

NIAID-Sponsored HIV/AIDS Research: Challenges for FY 2006 - Tony Fauci (not available for publication)